抑郁症中自杀念头的生物标志物:来自VMHC分析和机器学习的见解
Xinlin Wang1, Fei Liu1, Xinyi Hu1
1Department of Psychiatry, Tongji Hospital, School of Medicine, Tongji University, Shanghai, 200092, People's Republic of China.
Neuropsychiatric disease and treatment
|April 18, 2025
概括
患有严重抑郁症,有自杀念头的患者表现出大脑连接的改变. 沃克塞尔镜像同型连接 (VMHC) 异常可能作为神经成像生物标志物用于自杀风险评估.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 医疗成像医学成像
背景情况:
- 自杀念头 (SI) 是主要抑郁症 (MDD) 死亡的主要原因.
- 目前缺乏用于自杀风险评估的客观神经生物学标志物.
- 休息状态功能性磁共振成像 (rs-fMRI) 与voxel-mirrored同位素连接 (VMHC) 分析可以揭示精神障碍中的神经机制.
研究的目的:
- 为了调查与没有SI的MDD患者之间的半球间连接的差异.
- 使用VMHC识别潜在的自杀风险的神经成像生物标志物.
- 评估VMHC在区分有或没有SI的MDD患者的诊断效用.
主要方法:
- 招募了48名有SI的MDD患者和44名没有SI的MDD患者.
- 计算VMHC值以评估半球间功能连接.
- 采用支持矢量机 (SVM) 模型来评估VMHC的分类准确性.
主要成果:
- 患有SI的MDD患者在上额头回环,面,下回环和小脑中显著增加了VMHC.
- SVM模型实现了77.2%的准确度,83.3%的灵敏度,70.5%的特异性和0.81.1%的AUC.
- 结合来自多个地区的VMHC值,将分类准确度提高到86.8%.
结论:
- 异常的半球间连接,由特定大脑区域的VMHC变化表明,可能作为MDD中自杀风险的生物标志物.
- VMHC异常是早期检测和针对性干预自杀预防的潜在指标.
- 机器学习和神经成像的整合为自杀风险评估提供了一个有希望的方法.
相关概念视频
Depressive Disorders: Etiology
17
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
17
Antidepressant Drugs: MAOIs and Other Agents
160
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
160


